Mimedx (MDXG) Amortization of Deferred Charges (2011 - 2025)
Mimedx recorded quarterly Amortization of Deferred Charges of $135000.0 in Q1 2025, up 743.75% quarter-over-quarter from $16000.0 in Q3 2024, and up 95.65% year-over-year from $69000.0 in Q1 2024.
Mimedx's Amortization of Deferred Charges history runs 14 years deep, the most recent figure standing at $135000.0 for Q1 2025.
- In Q1 2025, Amortization of Deferred Charges rose 95.65% year-over-year to $135000.0; the TTM figure through Mar 2025 stood at $352000.0 (down 16.19% YoY), while the FY2023 annual figure was $505000.0, up 8.14% from the prior year.
- Amortization of Deferred Charges came in at $135000.0 for Q1 2025 at Mimedx, up from $16000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $415000.0 in Q1 2021 to a low of $16000.0 in Q3 2024.
- A 5-year average of $124714.3 and a median of $111500.0 in 2021 frame the typical range for Amortization of Deferred Charges.
- Across the five-year window, Amortization of Deferred Charges plunged 85.59% in 2024 and jumped 95.65% in 2025, its largest moves.
- Mimedx's Amortization of Deferred Charges stood at $112000.0 in 2021, then gained by 6.25% to $119000.0 in 2022, then increased by 10.92% to $132000.0 in 2023, then plunged by 87.88% to $16000.0 in 2024, then soared by 743.75% to $135000.0 in 2025.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $135000.0, $16000.0, and $69000.0 for Q1 2025, Q3 2024, and Q1 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 135,000.00 |
| Mar 31, 2025 | 135,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Mar 31, 2024 | 69,000.00 |
| Mar 31, 2024 | 69,000.00 |
| Dec 31, 2023 | 132,000.00 |
| Dec 31, 2023 | 132,000.00 |
| Sep 30, 2023 | 111,000.00 |
| Sep 30, 2023 | 111,000.00 |
| Jun 30, 2023 | 108,000.00 |
| Jun 30, 2023 | 108,000.00 |
| Mar 31, 2023 | 121,000.00 |
| Mar 31, 2023 | 121,000.00 |
| Dec 31, 2022 | 119,000.00 |
| Dec 31, 2022 | 119,000.00 |
| Sep 30, 2022 | 103,000.00 |
| Sep 30, 2022 | 103,000.00 |
| Jun 30, 2022 | 101,000.00 |
| Jun 30, 2022 | 101,000.00 |
| Mar 31, 2022 | 112,000.00 |
| Mar 31, 2022 | 112,000.00 |
| Dec 31, 2021 | 112,000.00 |
| Dec 31, 2021 | 112,000.00 |
| Jun 30, 2021 | 92,000.00 |
| Jun 30, 2021 | 92,000.00 |
| Mar 31, 2021 | 415,000.00 |
| Mar 31, 2021 | 415,000.00 |
| Dec 31, 2020 | 465,000.00 |
| Dec 31, 2020 | 465,000.00 |
| Sep 30, 2020 | 106,000.00 |
| Sep 30, 2020 | 106,000.00 |
| Jun 30, 2020 | 542,000.00 |
| Jun 30, 2020 | 542,000.00 |
| Mar 31, 2020 | 668,000.00 |
| Mar 31, 2020 | 668,000.00 |
| Dec 31, 2019 | 717,000.00 |
| Dec 31, 2019 | 717,000.00 |
| Sep 30, 2019 | 200,000.00 |
| Sep 30, 2019 | 200,000.00 |
| Jun 30, 2019 | 200,000.00 |
| Jun 30, 2019 | 200,000.00 |
| Dec 31, 2018 | 2,000.00 |
| Dec 31, 2018 | 2,000.00 |
| Sep 30, 2018 | 135,000.00 |
| Sep 30, 2018 | 135,000.00 |
| Jun 30, 2018 | -43,000.00 |
| Jun 30, 2018 | -43,000.00 |
| Mar 31, 2018 | 43,000.00 |
| Mar 31, 2018 | 43,000.00 |
| Dec 31, 2017 | -135,000.00 |
| Dec 31, 2017 | -135,000.00 |
| Sep 30, 2017 | 45,000.00 |
| Sep 30, 2017 | 45,000.00 |
| Jun 30, 2017 | 45,000.00 |
| Jun 30, 2017 | 45,000.00 |
| Mar 31, 2017 | 45,000.00 |
| Mar 31, 2017 | 45,000.00 |
| Dec 31, 2016 | 15,000.00 |
| Dec 31, 2016 | 15,000.00 |
| Sep 30, 2016 | 45,000.00 |
| Sep 30, 2016 | 45,000.00 |
| Jun 30, 2016 | 42,000.00 |
| Jun 30, 2016 | 42,000.00 |
| Mar 31, 2016 | 49,000.00 |
| Mar 31, 2016 | 49,000.00 |
| Dec 31, 2015 | 504,000.00 |
| Dec 31, 2015 | 504,000.00 |
| Dec 31, 2013 | -439.00 |
| Dec 31, 2013 | -439.00 |
| Mar 31, 2013 | 1.33 Mn |
| Mar 31, 2013 | 1.33 Mn |
| Dec 31, 2012 | -1.20 Mn |
| Dec 31, 2012 | -1.20 Mn |
| Sep 30, 2012 | 439,064.00 |
| Sep 30, 2012 | 439,064.00 |
| Jun 30, 2012 | 472,749.00 |
| Jun 30, 2012 | 472,749.00 |
| Mar 31, 2012 | 310,477.00 |
| Mar 31, 2012 | 310,477.00 |
| Dec 31, 2011 | -246,807.00 |
| Dec 31, 2011 | -246,807.00 |
| Sep 30, 2011 | 113,290.00 |
| Sep 30, 2011 | 113,290.00 |
| Jun 30, 2011 | 60,599.00 |
| Jun 30, 2011 | 60,599.00 |
| Mar 31, 2011 | 72,918.00 |
| Mar 31, 2011 | 72,918.00 |